Composición farmacéutica de didanosina

dc.contributorJose Ramon Ticó Grau
dc.contributorJose Maria Suñé Negre
dc.date2015-11-19T17:50:24Z
dc.date2015-11-19T17:50:24Z
dc.date2010
dc.date2010-01-05
dc.date2010-10-21
dc.date2007-11-14
dc.date.accessioned2023-09-27T00:11:12Z
dc.date.available2023-09-27T00:11:12Z
dc.identifierGRAU, Jose Ramon Ticó; NEGRÉ, Jose Maria Suñe. Composición farmacéutica de didanosina. ES2331501 A1, 14 nov. 2007. 28p.
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/12292
dc.identifierFundação Oswaldo Cruz. Brasil.
dc.identifierBlanver Farmoquímica Ltda. Brasil.
dc.identifierA61K 9/16
dc.identifierA61K 9/50
dc.identifierA61K 31/505
dc.identifierES200703002
dc.identifierES2331501 A1
dc.identifierES2331501 B1
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8898307
dc.descriptionThe present invention relates to a new solid pharmaceutical composition of didanosine comprising didanosine crystals with an average particle size comprised between 50 and 500 microns, coated by a layer of an enteric coating. The pharmaceutical composition of the invention can be prepared by means of a simple process, which comprises coating the didanosine crystals with an enteric layer. Said composition has a good stability of the active ingredient, as well as a suitable release in the conditions present in the upper part of the gastrointestinal tract. It also relates to the use of said composition for preparing solid dosage forms of didanosine for their oral administration. The invention also relates to tablets and to hard gelatin capsules containing said composition.
dc.descriptionEspanha
dc.descriptionPCT
dc.descriptionEuropa
dc.descriptionBrasil
dc.descriptionEspanha
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.languagespa
dc.rightsopen access
dc.titleComposición farmacéutica de didanosina
dc.typePatent


Este ítem pertenece a la siguiente institución